Centaurus Financial’s Biogen BIIB Stock Holding History

Centaurus Financial’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-404	Closed	-$114K	–	923
2021 Q3	$114K	Sell	404 -100	-20%	-$32.8K	0.01%	824
2021 Q2	$175K	Hold	504	–	–	0.01%	706
2021 Q1	$141K	Buy	+504	New	+$136K	0.01%	687
2020 Q3	–	Sell	-381	Closed	-$102K	–	646
2020 Q2	$102K	Buy	+381	New	+$115K	0.02%	595
2020 Q1	–	Sell	-667	Closed	-$198K	–	530
2019 Q4	$198K	Buy	+667	New	+$185K	0.03%	462
2019 Q3	–	Sell	-438	Closed	-$102K	–	459
2019 Q2	$102K	Hold	438	–	–	0.02%	576
2019 Q1	$104K	Buy	+438	New	+$138K	0.02%	529
2018 Q3	–	Sell	-104	Closed	-$30K	–	689
2018 Q2	$30K	Buy	+104	New	+$29.2K	﹤0.01%	1117

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Centaurus Financial's BIIB Position: Q4 2021 in Review

Centaurus Financial sold out of Biogen (BIIB) in Q4 2021, closing a stake of 404 shares — an estimated $114K sold.

Centaurus Financial first reported a position in BIIB in Q2 2018 and held it in 8 quarters. The position peaked at $198K in Q4 2019. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Centaurus Financial reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Centaurus Financial sold 404 Biogen shares in Q4 2021, an estimated $114K.
Centaurus Financial first reported a position in Biogen in Q2 2018 and held it in 8 quarters.
Centaurus Financial's Biogen position peaked at $198K in Q4 2019.
1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Centaurus Financial's 13F filing for Q4 2021, filed 1 Feb 2022.